Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1063-1072

  Garcia, Jenny A ^a   Pino, Paula A ^a   Mizutani, Makiko ^b   Cardona, Sandra M ^a   Charo, Israel F ^c   Ransohoff, Richard M ^b   Forsthuber, Thomas G ^a   Cardona, Astrid E ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; INTERLEUKIN 17F; OLIGODENDROCYTE MYELIN GLYCOPROTEIN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEMYELINATION; DENDRITIC CELL; DISEASE SEVERITY; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NEURONAL DAMAGE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; SPINAL CORD; T LYMPHOCYTE; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD11C; ANTIGENS, LY; AUTOIMMUNITY; BONE MARROW CELLS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHIMERA; DEMYELINATING DISEASES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MYELOID CELLS; PEPTIDE FRAGMENTS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, HIV; T-LYMPHOCYTES;

EID: 84880658105     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300040     Document Type: Article

References (47)

1. Cardona, A. E., M. E. Sasse, L. Liu, S. M. Cardona, M. Mizutani, C. Savarin, T. Hu, and R. M. Ransohoff. 2008. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112: 256-263.
2. Cardona, A. E., E. P. Pioro, M. E. Sasse, V. Kostenko, S. M. Cardona, I. M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, R. Dutta, et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9: 917-924.
3. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membranebound chemokine with a CX3C motif. Nature 385: 640-644.
4. Rossi, D. L., G. Hardiman, N. G. Copeland, D. J. Gilbert, N. Jenkins, A. Zlotnik, and J. F. Bazan. 1998. Cloning and characterization of a new type of mouse chemokine. Genomics 47: 163-170.
5. Combadiere, C., K. Salzwedel, E. D. Smith, H. L. Tiffany, E. A. Berger, and P. M. Murphy. 1998. Identification of CX3CR1: a chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273: 23799-23804.
6. Mizoue, L. S., J. F. Bazan, E. C. Johnson, and T. M. Handel. 1999. Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38: 1402-1414.
7. Hatori, K., A. Nagai, R. Heisel, J. K. Ryu, and S. U. Kim. 2002. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69: 418-426.
8. Tuo, J., B. C. Smith, C. M. Bojanowski, A. D. Meleth, I. Gery, K. G. Csaky, E. Y. Chew, and C. C. Chan. 2004. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 18: 1297-1299.
9. Chan, C. C., J. Tuo, C. M. Bojanowski, K. G. Csaky, and W. R. Green. 2005. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol. Histopathol. 20: 857-863.
10. Moatti, D., S. Faure, F. Fumeron, Mel.-W. Amara, P. Seknadji, D. H. McDermott, P. Debré, M. C. Aumont, P. M. Murphy, D. de Prost, and C. Combadiére. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925-1928.
11. Nassar, B. A., A. A. Nanji, T. P. Ransom, K. Rockwood, S. A. Kirkland, K. Macpherson, P. W. Connelly, D. E. Johnstone, B. J. O'Neill, I. R. Bata, et al. 2008. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors. Scand. J. Clin. Lab. Invest. 68: 286-291.
12. McDermott, D. H., A. M. Fong, Q. Yang, J. M. Sechler, L. A. Cupples, M. N. Merrell, P. W. Wilson, R. B. D'Agostino, C. J. O'Donnell, D. D. Patel, and P. M. Murphy. 2003. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111: 1241-1250.
13. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670.
14. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
15. Geissmann, F., S. Gordon, D. A. Hume, A. M. Mowat, and G. J. Randolph. 2010. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10: 453-460.
16. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
17. Geissmann, F., C. Auffray, R. Palframan, C. Wirrig, A. Ciocca, L. Campisi, E. Narni-Mancinelli, and G. Lauvau. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of Tcell responses. Immunol. Cell Biol. 86: 398-408.
18. Mizutani, M., P. A. Pino, N. Saederup, I. F. Charo, R. M. Ransohoff, and A. E. Cardona. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188: 29-36.
19. Saederup, N., A. E. Cardona, K. Croft, M. Mizutani, A. C. Cotleur, C. L. Tsou, R. M. Ransohoff, and I. F. Charo. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 5: e13693.
20. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
21. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
22. Thakker, P., M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic. 2007. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178: 2589-2598.
23. Pino, P. A., and A. E. Cardona. 2011. Isolation of brain and spinal cord mononuclear cells using Percoll gradients. J. Vis. Exp. 48: e2348.
24. Haskell, C. A., W. W. Hancock, D. J. Salant, W. Gao, V. Csizmadia, W. Peters, K. Faia, O. Fituri, J. B. Rottman, and I. F. Charo. 2001. Targeted deletion of CX (3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J. Clin. Invest. 108: 679-688.
25. Jung, S., J. Aliberti, P. Graemmel, M. J. Sunshine, G. W. Kreutzberg, A. Sher, and D. R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20: 4106-4114.
26. Haskell, C. A., M. D. Cleary, and I. F. Charo. 2000. Unique role of the chemokine domain of fractalkine in cell capture: kinetics of receptor dissociation correlate with cell adhesion. J. Biol. Chem. 275: 34183-34189.
27. Haskell, C. A., M. D. Cleary, and I. F. Charo. 1999. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction: rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J. Biol. Chem. 274: 10053-10058.
28. Huang, D., F. D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H. G. Ljunggren, C. A. Biron, et al. 2006. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20: 896-905.
29. Prinz, M., J. Priller, S. S. Sisodia, and R. M. Ransohoff. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14: 1227-1235.
30. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
31. Thomas, D. M., D. M. Francescutti-Verbeem, and D. M. Kuhn. 2008. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. J. Neurochem. 106: 696-705.
32. Meucci, O., A. Fatatis, A. A. Simen, and R. J. Miller. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97: 8075-8080.
33. Lauro, C., S. Di Angelantonio, R. Cipriani, F. Sobrero, L. Antonilli, V. Brusadin, D. Ragozzino, and C. Limatola. 2008. Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 180: 7590-7596.
34. Lauro, C., R. Cipriani, M. Catalano, F. Trettel, G. Chece, V. Brusadin, L. Antonilli, N. van Rooijen, F. Eusebi, B. B. Fredholm, and C. Limatola. 2010. Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 35: 1550-1559.
35. Dénes, A., S. Ferenczi, J. Halász, Z. Környei, and K. J. Kovács. 2008. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 28: 1707-1721.
36. Sabate, J. M., N. Ameziane, J. Lamoril, P. Jouet, J. P. Farmachidi, J. C. Soulé, F. Harnois, I. Sobhani, R. Jian, J. C. Deybach, et al. 2008. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 20: 748-755.
37. McDermott, D. H., J. P. Halcox, W. H. Schenke, M. A.Waclawiw, M. N. Merrell, N. Epstein, A. A. Quyyumi, and P. M. Murphy. 2001. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ. Res. 89: 401-407.
38. Apostolakis, S., S. Baritaki, G. E. Kochiadakis, N. E. Igoumenidis, D. Panutsopulos, and D. A. Spandidos. 2007. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb. Res. 119: 63-71.
39. Apostolakis, S., V. Amanatidou, E. G. Papadakis, and D. A. Spandidos. 2009. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-Analysis. Atherosclerosis 207: 8-15.
40. Stojković, L., T. Djurić, A. Stanković, E. Din?cić, O. Stan?cić, N. Veljković, D. Alavantić, and M. Zivković. 2012. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis. J. Neuroimmunol. 245: 87-92.
41. Broux, B., K. Pannemans, X. Zhang, S. Markovic-Plese, T. Broekmans, B. O. Eijnde, B. Van Wijmeersch, V. Somers, P. Geusens, S. van der Pol, et al. 2012. CX(3)CR1 drives cytotoxic CD4(+)CD28(2) T cells into the brain of multiple sclerosis patients. J. Autoimmun. 38: 10-19.
42. Kruglov, A. A., V. Lampropoulou, S. Fillatreau, and S. A. Nedospasov. 2011. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells. J. Immunol. 187: 5660-5670.
43. Murphy, C. A., R. M. Hoek, M. T. Wiekowski, S. A. Lira, and J. D. Sedgwick. 2002. Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J. Immunol. 169: 7054-7062.
44. Renno, T., M. Krakowski, C. Piccirillo, J. Y. Lin, and T. Owens. 1995. TNFalpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J. Immunol. 154: 944-953.
45. Sriram, K., J. M. Matheson, S. A. Benkovic, D. B. Miller, M. I. Luster, and J. P. O'Callaghan. 2006. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-Alpha. FASEB J. 20: 670-682.
46. Omari, K. M., and K. Dorovini-Zis. 2003. CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium. J. Neuroimmunol. 134: 166-178.
47. Shrikant, P., I. Y. Chung, M. E. Ballestas, and E. N. Benveniste. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factoralpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51: 209-220.